NEW YORK (Reuters Health) – In patients with active psoriatic arthritis, daily oral upadacitinib produces significantly more improvement than placebo,
Upadacitinib Shows Benefit in Psoriatic Arthritis, Higher Dose Bests Adalimumab
Home ยป
Our Journeys With Chronic Illness Aren't Meant to Be Solo
Life with an invisible illness presents many challenges. For me, one of the biggest challenges is an extreme sense of
State Lawmakers Propose Tough New Bills to Curb Drug Prices
Fed up with a lack of federal action to lower prescription drug costs, state legislators around the country are pushing